Pfizer and Astellas invite proposals for independent medical education that address gaps in the evolving MIBC landscape and translate emerging data into practice for multidisciplinary teams in the U.S.
Eligibility Criteria:
-
U.S. scope; organizations only (e.g., schools, healthcare institutions, professional societies, accredited CE providers, medical education companies). Individuals and unaffiliated practice groups are ineligible.
-
Requesting organization must be able to receive funds directly from Pfizer; for CE projects, the requester must be accredited.
Funding Details:
-
Requested amount: USD 10,000–220,000 per project; total RFP budget ~USD 500,000. Overheads capped at 28% per Pfizer policy. Project length: 18–24 months.
-
Focus areas include unmet needs with current systemic therapies, perioperative therapies (use and AE management), ADCs and targeted MOA, and best practices in multidisciplinary coordination and shared decision-making.
Deadline:
-
Submission Deadline: November 12, 2025 (23:59 EST)
-
Anticipated Award Notification: December 2025
-
Anticipated Project Start: February 2026 | End: January 2027
Where To Go For Further Information: